Skip to content
drillr.ai

ALKS

Alkermes plc

NASDAQ · IEHealthcareBiotechnology
$51.72-1.90%

Price as of Jul 20, 2026

ALKS news

Alkermes plc news

A server-rendered, paginated timeline of the latest available company news.

  1. Alkermes to Report Second Quarter Financial Results on July 28, 2026

    Alkermes to Report Second Quarter Financial Results on July 28, 2026 Alkermes plc (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.alkermes.com&esheet=54570295&newsitemid=20260714358215&lan=en-US&anchor=Alkermes+plc&index=1&md5=31fc23ddf13543bed6b8283cf297b6cb) (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Tuesday, July 28, 2026 to discuss the company’s second quarter financial results. The webcast player and accompa

    Business Wire ·

  2. Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

    Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026 — First Large Phase 2 Study of an Orexin 2 Receptor Agonist to Demonstrate Clinically Meaningful and Statistically Significant Improvements in Wakefulness and Excessive Daytime Sleepiness Compared to Placebo in Narcolepsy Type 2 — — Improvements in Wakefulness and Patient-Reported Cognition and Fatigue Were Sustained Through 13 Weeks — — Alixorexton Was Gener

    Business Wire ·

  3. Alkermes to Report First Quarter Financial Results on May 5, 2026

    Alkermes to Report First Quarter Financial Results on May 5, 2026 Alkermes plc (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.alkermes.com&esheet=54519751&newsitemid=20260421663094&lan=en-US&anchor=Alkermes+plc&index=1&md5=5dbd6dccf710e3cab8f5184790aac586) (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Tuesday, May 5, 2026 to discuss the company’s first quarter financial results. The webcast player and accompanying

    Business Wire ·